Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:2244-2249
Published online before print October 7, 2002, doi: 10.1161/01.CIR.0000033826.52681.37
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/17/2244    most recent
01.CIR.0000033826.52681.37v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ichihara, S.
Right arrow Articles by Inagami, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ichihara, S.
Right arrow Articles by Inagami, T.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrowRelated Article

(Circulation. 2002;106:2244.)
© 2002 American Heart Association, Inc.


Basic Science Reports

Targeted Deletion of Angiotensin II Type 2 Receptor Caused Cardiac Rupture After Acute Myocardial Infarction

Sahoko Ichihara, MD, PhD; Takaaki Senbonmatsu, MD, PhD; Edward Price, Jr, MS; Toshihiro Ichiki, MD, PhD; F. Andrew Gaffney, MD; Tadashi Inagami, PhD

From the Departments of Biochemistry (S.I., T.S., E.P., T. Ichiki, T. Inagami) and Medicine (F.A.G.), Vanderbilt University School of Medicine, Nashville, Tenn.

Correspondence to Tadashi Inagami, PhD, Department of Biochemistry, Vanderbilt University School of Medicine, 663 Light Hall, 23rd at Pierce Ave, Nashville, TN 37232-0146. E-mail tadashi.inagami{at}vanderbilt.edu

Background— Accumulating evidence has suggested that the cardiac renin-angiotensin system is activated during the remodeling process after myocardial infarction (MI). Although 2 types of angiotensin II receptors (AT1 and AT2) are upregulated in the infarcted tissue, the contribution of AT2 to the subsequent fibrogenetic phase of wound healing is less certain. This study was conducted to evaluate the role of AT2 in wound healing after MI using an in vivo intervention study in mice with MI.

Methods and Results— We examined myocardial hypertrophy, cardiac fibrosis, and morphological evidence of fibrillar collagen accumulation at the infarcted and noninfarcted regions in male mice lacking the AT2 receptor (Agtr2-/Y) and age-matched wild-type (WT) animals. Of the Agtr2-/Y mice, 63.6% died of cardiac rupture, whereas 23.5% of the WT mice died of the same cause within 1 week. The extent of fibrosis and that of collagen gene expression in Agtr2-/Y mice were significantly reduced compared with WT mice at 1 week after coronary ligation. Furthermore, MI resulted in a marked increase in the prostaglandin E2 (PGE2) level at 4 days after surgery in Agtr2-/Y mice. In WT mice, the PGE2 level was also elevated after MI but to a significantly lesser extent than in Agtr2-/Y mice.

Conclusions— A chronic loss of AT2 by gene targeting prevented the collagen deposition and caused cardiac rupture. The markedly elevated PGE2 may be a mechanism that inhibits collagen synthesis in the infarcted region of Agtr2-/Y mice.


Key Words: angiotensin • collagen • myocardial infarction • prostaglandins • remodeling


Related Article:

Renin-Angiotensin System and Cardiac Rupture After Myocardial Infarction
Scott D. Solomon and Marc A. Pfeffer
Circulation 2002 106: 2167-2169. [Full Text]



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Yang, Y. Ma, W. Han, J. Li, Y. Xiang, F. Liu, X. Ma, J. Zhang, Z. Fu, Y.-D. Su, et al.
Age-related differences in postinfarct left ventricular rupture and remodeling
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1815 - H1822.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. Shimazaki, K. Nakamura, I. Kii, T. Kashima, N. Amizuka, M. Li, M. Saito, K. Fukuda, T. Nishiyama, S. Kitajima, et al.
Periostin is essential for cardiac healingafter acute myocardial infarction
J. Exp. Med., February 18, 2008; 205(2): 295 - 303.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. C. Isbell, S. Voros, Z. Yang, J. M. DiMaria, S. S. Berr, B. A. French, F. H. Epstein, S. P. Bishop, H. Wang, R. J. Roy, et al.
Interaction between bradykinin subtype 2 and angiotensin II type 2 receptors during post-MI left ventricular remodeling
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3372 - H3378.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Oka, J. Xu, R. A. Kaiser, J. Melendez, M. Hambleton, M. A. Sargent, A. Lorts, E. W. Brunskill, G. W. Dorn II, S. J. Conway, et al.
Genetic Manipulation of Periostin Expression Reveals a Role in Cardiac Hypertrophy and Ventricular Remodeling
Circ. Res., August 3, 2007; 101(3): 313 - 321.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Fielitz, E. van Rooij, J. A. Spencer, J. M. Shelton, S. Latif, R. van der Nagel, S. Bezprozvannaya, L. de Windt, J. A. Richardson, R. Bassel-Duby, et al.
Loss of muscle-specific RING-finger 3 predisposes the heart to cardiac rupture after myocardial infarction
PNAS, March 13, 2007; 104(11): 4377 - 4382.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Voros, Z. Yang, C. M. Bove, W. D. Gilson, F. H. Epstein, B. A. French, S. S. Berr, S. P. Bishop, M. R. Conaway, H. Matsubara, et al.
Interaction between AT1 and AT2 receptors during postinfarction left ventricular remodeling
Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1004 - H1010.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Ichihara, A. Noda, K. Nagata, K. Obata, J. Xu, G. Ichihara, S. Oikawa, S. Kawanishi, Y. Yamada, and M. Yokota
Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure
Cardiovasc Res, February 15, 2006; 69(3): 726 - 735.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Warnecke, P. Mugrauer, D. Surder, J. Erdmann, C. Schubert, and V. Regitz-Zagrosek
Intronic ANG II type 2 receptor gene polymorphism 1675 G/A modulates receptor protein expression but not mRNA splicing
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1729 - R1735.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Ertl and S. Frantz
Healing after myocardial infarction
Cardiovasc Res, April 1, 2005; 66(1): 22 - 32.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Ertl and S. Frantz
Wound model of myocardial infarction
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H981 - H983.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
X.-M. Gao, Q. Xu, H. Kiriazis, A. M. Dart, and X.-J. Du
Mouse model of post-infarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology
Cardiovasc Res, February 1, 2005; 65(2): 469 - 477.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Kawakami, Y. Saito, I. Kishimoto, M. Harada, K. Kuwahara, N. Takahashi, Y. Nakagawa, M. Nakanishi, K. Tanimoto, S. Usami, et al.
Overexpression of Brain Natriuretic Peptide Facilitates Neutrophil Infiltration and Cardiac Matrix Metalloproteinase-9 Expression After Acute Myocardial Infarction
Circulation, November 23, 2004; 110(21): 3306 - 3312.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Sun, F. Dawood, W.-H. Wen, M. Chen, I. Dixon, L. A. Kirshenbaum, and P. P. Liu
Excessive Tumor Necrosis Factor Activation After Infarction Contributes to Susceptibility of Myocardial Rupture and Left Ventricular Dysfunction
Circulation, November 16, 2004; 110(20): 3221 - 3228.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Kaikita, T. Hayasaki, T. Okuma, W. A. Kuziel, H. Ogawa, and M. Takeya
Targeted Deletion of CC Chemokine Receptor 2 Attenuates Left Ventricular Remodeling after Experimental Myocardial Infarction
Am. J. Pathol., August 1, 2004; 165(2): 439 - 447.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
O. Johren, A. Dendorfer, and P. Dominiak
Cardiovascular and renal function of angiotensin II type-2 receptors
Cardiovasc Res, June 1, 2004; 62(3): 460 - 467.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. M. Bove, Z. Yang, W. D. Gilson, F. H. Epstein, B. A. French, S. S. Berr, S. P. Bishop, H. Matsubara, R. M. Carey, and C. M. Kramer
Nitric Oxide Mediates Benefits of Angiotensin II Type 2 Receptor Overexpression During Post-Infarct Remodeling
Hypertension, March 1, 2004; 43(3): 680 - 685.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Brede, W. Roell, O. Ritter, F. Wiesmann, R. Jahns, A. Haase, B. K. Fleischmann, and L. Hein
Cardiac Hypertrophy Is Associated With Decreased eNOS Expression in Angiotensin AT2 Receptor-Deficient Mice
Hypertension, December 1, 2003; 42(6): 1177 - 1182.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. I. Jugdutt
Ventricular Remodeling After Infarction and the Extracellular Collagen Matrix: When Is Enough Enough?
Circulation, September 16, 2003; 108(11): 1395 - 1403.
[Full Text] [PDF]


Home page
CirculationHome page
Y. Adachi, Y. Saito, I. Kishimoto, M. Harada, K. Kuwahara, N. Takahashi, R. Kawakami, M. Nakanishi, Y. Nakagawa, K. Tanimoto, et al.
Angiotensin II Type 2 Receptor Deficiency Exacerbates Heart Failure and Reduces Survival After Acute Myocardial Infarction in Mice
Circulation, May 20, 2003; 107(19): 2406 - 2408.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. D. Solomon and M. A. Pfeffer
Renin-Angiotensin System and Cardiac Rupture After Myocardial Infarction
Circulation, October 22, 2002; 106(17): 2167 - 2169.
[Full Text] [PDF]